Translating Research Into Practice
Locally Advanced Rectal Cancer: Does Assessment of Response After Neoadjuvant Chemoradiotherapy Impact Management?
Elizabeth A. Wolf, PA-C, and Daniel L. Malatek, PA-C
From MD Anderson Cancer Center, Houston, Texas
The authors have no conflicts of interest to disclose.
Correspondence to: Elizabeth A. Wolf, PA-C, 19770 Kingsland Boulevard, Houston, TX 77094. E-mail: ewolf@mdanderson.org
J Adv Pract Oncol 2013;4:438–444 |
DOI: 10.6004/jadpro.2013.4.6.9 |
© 2013 Harborside Press®
ABSTRACT
Review of “Neoadjuvant treatment response as an early response indicator for patients with rectal cancer” by Park et al. (2012), Journal of Clinical Oncology, 15, 1770–1776. For another perspective on the Park et al. study, please see the related article by Annie R. Truong and Steven H. Wei starting on page 445.
For access to the full length article, please
sign in.
